Clinical Trial: A Trial of HRS-3095 in Healthy Volunteers

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07686484) titled 'A Trial of HRS-3095 in Healthy Volunteers' on June 22.

Brief Summary: The purpose of this study is to assess safety, PK, Pharmacodynamic profile of a single dose of HRS-3095 in healthy participants

Study Start Date: July 30

Study Type: INTERVENTIONAL

Condition: Chronic Spontaneous Urticaria

Intervention: DRUG: HRS-3095

Single dose HRS-3095 /placebo given orally - Dose level 1

DRUG: HRS-3095

Single dose HRS-3095 /placebo given orally - Dose level 2

DRUG: HRS-3095

Single dose HRS-3095 /placebo given orally - Dose level 3

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Atridia Pty Ltd.

Disclaimer: Curated by HT Syndication...